Company Filing History:
Years Active: 2003-2012
Title: Thomas Schwan: Innovator in Bacterial Adhesion Research
Introduction
Thomas Schwan is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of molecular biology, particularly in understanding bacterial adhesion mechanisms. His work has implications for developing new therapeutic strategies against bacterial infections.
Latest Patents
Thomas Schwan holds 2 patents that focus on nucleic acid molecules encoding proteins that mediate the adhesion of bacteria to human cells. His latest patents describe nucleic acid molecules that encode proteins facilitating the adhesion of bacteria from the genus Neisseria to human cells. Additionally, these patents detail the proteins encoded by these nucleic acid molecules and the antibodies directed against them. Furthermore, they encompass pharmaceutical compositions, vaccines, and diagnostic compositions containing these nucleic acid molecules, proteins, and/or antibodies.
Career Highlights
Thomas Schwan is affiliated with the Max Planck Society for the Advancement of Science, where he conducts his research. His work has been instrumental in advancing our understanding of bacterial interactions with human cells, paving the way for innovative medical solutions.
Collaborations
Some of his notable coworkers include Thomas F. Meyer and Thomas Rudel, who have collaborated with him on various research projects.
Conclusion
Thomas Schwan's innovative research in bacterial adhesion has the potential to lead to significant advancements in medical science. His contributions are vital in the ongoing battle against bacterial infections.